S&P 500   3,095.03 (+0.03%)
DOW   27,769.53 (-0.05%)
QQQ   201.31 (-0.14%)
CGC   15.99 (-13.57%)
BABA   181.62 (-0.47%)
GE   11.30 (+0.09%)
T   38.88 (-0.72%)
F   8.80 (-0.23%)
ACB   3.25 (-8.46%)
DIS   147.73 (-0.67%)
S&P 500   3,095.03 (+0.03%)
DOW   27,769.53 (-0.05%)
QQQ   201.31 (-0.14%)
CGC   15.99 (-13.57%)
BABA   181.62 (-0.47%)
GE   11.30 (+0.09%)
T   38.88 (-0.72%)
F   8.80 (-0.23%)
ACB   3.25 (-8.46%)
DIS   147.73 (-0.67%)
S&P 500   3,095.03 (+0.03%)
DOW   27,769.53 (-0.05%)
QQQ   201.31 (-0.14%)
CGC   15.99 (-13.57%)
BABA   181.62 (-0.47%)
GE   11.30 (+0.09%)
T   38.88 (-0.72%)
F   8.80 (-0.23%)
ACB   3.25 (-8.46%)
DIS   147.73 (-0.67%)
S&P 500   3,095.03 (+0.03%)
DOW   27,769.53 (-0.05%)
QQQ   201.31 (-0.14%)
CGC   15.99 (-13.57%)
BABA   181.62 (-0.47%)
GE   11.30 (+0.09%)
T   38.88 (-0.72%)
F   8.80 (-0.23%)
ACB   3.25 (-8.46%)
DIS   147.73 (-0.67%)
Log in

Fonar Stock Price, Forecast & Analysis (NASDAQ:FONR)

$20.30
+0.10 (+0.50 %)
(As of 11/14/2019 03:04 PM ET)
Today's Range
$20.11
Now: $20.30
$20.30
50-Day Range
$19.61
MA: $20.26
$21.62
52-Week Range
$18.85
Now: $20.30
$25.25
Volume1,489 shs
Average Volume16,237 shs
Market Capitalization$130.94 million
P/E Ratio9.40
Dividend YieldN/A
Beta0.69
FONAR Corporation, together with its subsidiaries, operates as a magnetic resonance imaging (MRI) company primarily in the Unites States. It is involved in the research, development, production, and marketing of medical scanning equipment, which uses principles of MRI for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries. The company operates in two segments, Manufacturing and Servicing of Medical Equipment, and Management of Diagnostic Imaging Centers. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company markets its scanners to private diagnostic imaging centers and hospitals. It also provides non-medical management services, including development, administration, office space leasing, facilities, equipment, supplies, staffing, credentialing, accounting, billing and collection, assistance with compliance matters, and practice growth and marketing strategies development and implementation services, as well as engages in the training and supervision of non-medical personnel for diagnostic imaging facilities. The company also exports its products to the United Arab Emirates, Switzerland, Canada, England, Germany, and Puerto Rico. It owns and operates 4 diagnostic imaging facilities in Florida; and manages 26 MRI scanning facilities, including 19 facilities located in New York and 7 situated in Florida. The company was founded in 1978 and is based in Melville, New York.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:FONR
CUSIPN/A
Phone631-694-2929

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$87.19 million
Cash Flow$2.80 per share
Book Value$18.58 per share

Profitability

Net Income$15.32 million

Miscellaneous

EmployeesN/A
Market Cap$130.94 million
Next Earnings Date2/10/2020 (Estimated)
OptionableNot Optionable

Receive FONR News and Ratings via Email

Sign-up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter.


Fonar (NASDAQ:FONR) Frequently Asked Questions

What is Fonar's stock symbol?

Fonar trades on the NASDAQ under the ticker symbol "FONR."

How were Fonar's earnings last quarter?

Fonar Co. (NASDAQ:FONR) issued its quarterly earnings data on Friday, September, 13th. The medical equipment provider reported $0.66 earnings per share (EPS) for the quarter. The medical equipment provider had revenue of $22.48 million for the quarter. Fonar had a net margin of 16.48% and a return on equity of 12.80%. View Fonar's Earnings History.

When is Fonar's next earnings date?

Fonar is scheduled to release their next quarterly earnings announcement on Monday, February 10th 2020. View Earnings Estimates for Fonar.

Has Fonar been receiving favorable news coverage?

News headlines about FONR stock have trended somewhat negative recently, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Fonar earned a news impact score of -1.4 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Fonar.

Are investors shorting Fonar?

Fonar saw a decrease in short interest in October. As of October 15th, there was short interest totalling 19,500 shares, a decrease of 8.9% from the September 15th total of 21,400 shares. Based on an average daily volume of 32,700 shares, the days-to-cover ratio is presently 0.6 days. Approximately 0.3% of the company's stock are short sold. View Fonar's Current Options Chain.

Who are some of Fonar's key competitors?

What other stocks do shareholders of Fonar own?

Who are Fonar's key executives?

Fonar's management team includes the folowing people:
  • Dr. Raymond V. Damadian, Chairman, Principal Financial Officer & Treasurer (Age 83)
  • Mr. Timothy R. Damadian, CEO & Pres (Age 55)
  • Mr. Luciano B. Bonanni, COO & Exec. VP (Age 64)
  • Ms. Claudette J. V. Chan, Sec. & Director (Age 81)
  • Mr. Daniel Culver, Director of Communications

Who are Fonar's major shareholders?

Fonar's stock is owned by many different of institutional and retail investors. Top institutional investors include California Public Employees Retirement System (0.75%), First Trust Advisors LP (0.22%), Hancock Whitney Corp (0.16%), Tower Research Capital LLC TRC (0.07%) and Cascade Investment Advisors Inc. (0.02%). Company insiders that own Fonar stock include Raymond V Damadian and Robert J Janoff. View Institutional Ownership Trends for Fonar.

Which institutional investors are selling Fonar stock?

FONR stock was sold by a variety of institutional investors in the last quarter, including Hancock Whitney Corp. View Insider Buying and Selling for Fonar.

Which institutional investors are buying Fonar stock?

FONR stock was purchased by a variety of institutional investors in the last quarter, including Tower Research Capital LLC TRC , First Trust Advisors LP, California Public Employees Retirement System and Cascade Investment Advisors Inc.. View Insider Buying and Selling for Fonar.

How do I buy shares of Fonar?

Shares of FONR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Fonar's stock price today?

One share of FONR stock can currently be purchased for approximately $20.30.

How big of a company is Fonar?

Fonar has a market capitalization of $130.94 million and generates $87.19 million in revenue each year. View Additional Information About Fonar.

What is Fonar's official website?

The official website for Fonar is http://www.fonar.com/.

How can I contact Fonar?

Fonar's mailing address is 110 Marcus Drive, Melville NY, 11747. The medical equipment provider can be reached via phone at 631-694-2929 or via email at [email protected]


MarketBeat Community Rating for Fonar (NASDAQ FONR)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  118 (Vote Outperform)
Underperform Votes:  99 (Vote Underperform)
Total Votes:  217
MarketBeat's community ratings are surveys of what our community members think about Fonar and other stocks. Vote "Outperform" if you believe FONR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FONR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel